These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 20148243)

  • 1. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.
    Guan F; Uboh CE; Soma LR; Maylin G; Jiang Z; Chen J
    Anal Chem; 2010 Nov; 82(21):9074-81. PubMed ID: 20945883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma.
    Guan F; Uboh CE; Soma LR; Birks E; Chen J; Mitchell J; You Y; Rudy J; Xu F; Li X; Mbuy G
    Anal Chem; 2007 Jun; 79(12):4627-35. PubMed ID: 17500535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screen and confirmation of PEG-epoetin β in equine plasma.
    Chang Y; Maylin GM; Matsumoto G; Neades SM; Catlin DH
    Drug Test Anal; 2011 Jan; 3(1):68-73. PubMed ID: 21254454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation and identification of recombinant human erythropoietin and darbepoetin Alfa in equine plasma by LC-MS/MS for doping control.
    Guan F; Uboh CE; Soma LR; Birks E; Chen J; You Y; Rudy J; Li X
    Anal Chem; 2008 May; 80(10):3811-7. PubMed ID: 18380469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control.
    Guan F; Uboh CE; Soma LR; Birksz E; Chen J
    Int J Sports Med; 2009 Feb; 30(2):80-6. PubMed ID: 19177313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control analysis of filgrastim in equine plasma and its application to a co-administration study of filgrastim and recombinant human erythropoietin in the horse.
    Ho EN; Kwok WH; Lau MY; Wong AS; Lam KK; Stewart BD; Wan TS
    J Chromatogr A; 2014 Apr; 1338():92-101. PubMed ID: 24636755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography-tandem mass spectrometry.
    Okano M; Sato M; Kageyama S
    Anal Bioanal Chem; 2014 Feb; 406(5):1317-29. PubMed ID: 23443522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
    Möller I; Thomas A; Wingender A; Machnik M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2012; 18(4):407-12. PubMed ID: 22971699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Bredehöft M; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection of recombinant growth hormones in equine plasma by liquid chromatography/high-resolution tandem mass spectrometry for doping control.
    Wong KS; Chan GHM; Ho ENM; Wan TSM
    J Chromatogr A; 2016 Dec; 1478():35-42. PubMed ID: 27914605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low LC-MS/MS detection of glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow HPLC-chip electrospray ionization.
    Groleau PE; Desharnais P; Coté L; Ayotte C
    J Mass Spectrom; 2008 Jul; 43(7):924-35. PubMed ID: 18563860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
    Wilber RL
    Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
    Bailly-Chouriberry L; Cormant F; Garcia P; Lönnberg M; Szwandt S; Bondesson U; Popot MA; Bonnaire Y
    Analyst; 2012 May; 137(10):2445-53. PubMed ID: 22454833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
    Dehnes Y; Shalina A; Myrvold L
    Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
    Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.
    De Leo M; Giorgi M; Saccomanni G; Manera C; Braca A
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):228-36. PubMed ID: 19072864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry.
    Stübiger G; Marchetti M; Nagano M; Reichel C; Gmeiner G; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(5):728-42. PubMed ID: 15700237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.